Crispr/Cas9, oligodirected mutagenesis, zinc finger nuclease… Those names are a few of a longer list of new techniques of biotechnologies (NTB) for which the European Union is still to decide whether their products are falling under the scope of the EU GMO legislation or not. After having consulted with scientists experts, legal services and some member states, the European Commission has promised it will release a document before the end of 2015. If any were expecting this document to be discussed with the European Parliament and all the Member states, they had it wrong as the European